EVEREST ORGANICS
Back to Balance Sheet
|
EVEREST ORGANICS Last 5 Year Deferred Tax Assets / Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹2.00 Cr | ₹4.52 Cr | ₹4.15 Cr | ₹3.89 Cr | ₹3.58 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of EVEREST ORGANICS ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹2.00 Cr |
| Mar2024 | ₹4.52 Cr |
| Mar2023 | ₹4.15 Cr |
| Mar2022 | ₹3.89 Cr |
| Mar2021 | ₹3.58 Cr |
How is Deferred Tax Assets / Liabilities of EVEREST ORGANICS Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹2.00 Cr | -55.63 | |
| Mar2024 | ₹4.52 Cr | 8.95 | |
| Mar2023 | ₹4.15 Cr | 6.61 | |
| Mar2022 | ₹3.89 Cr | 8.54 | |
| Mar2021 | ₹3.58 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of EVEREST ORGANICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EVEREST ORGANICS | ₹217.1 Cr | -1.5% | -38.3% | -10% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,603.0 Cr | -5.6% | -2.5% | -1.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹155,485.0 Cr | -2.6% | -8.7% | 1.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,009.0 Cr | -7.2% | -8% | 27.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,628.0 Cr | -6.5% | -5.4% | 3.9% | Stock Analytics | |
| CIPLA | ₹96,400.8 Cr | -4.1% | -11.5% | -19% | Stock Analytics | |
EVEREST ORGANICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EVEREST ORGANICS | -1.5% |
-38.3% |
-10% |
| SENSEX | -1% |
-10.9% |
-6% |
You may also like the below Video Courses